Related Experiment Video
Updated: Dec 31, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Cardiac Murmur in a Boy with Normal Paternal Prenatal Carrier Screening for Pompe Disease
Allison M Jay1, Premchand Anne2, David Stockton3
1Division of Genetics, Ascension St. John Hospital, Detroit, MI, USA.
Insights
A normal paternal carrier genetic test does not rule out Pompe disease. Early infantile Pompe disease diagnosis is crucial, even with prior normal parental screening, as retesting revealed a missed mutation.
Area of Science:
- Genetics
- Metabolic Disorders
- Pediatrics
Background:
- Pompe disease is a severe autosomal recessive lysosomal storage disorder.
- Early identification of infantile-onset Pompe disease is critical for effective enzyme replacement therapy.
- Prenatal diagnosis and newborn screening are key strategies for early detection.
Observation:
- A case of infantile-onset Pompe disease is presented in an infant born before widespread newborn screening.
- The infant's father initially had a normal paternal carrier genetic test.
- Postnatal diagnosis prompted retesting, revealing a mutation in the father consistent with Pompe disease.
Findings:
- Prenatal parental carrier screening may not detect all cases of Pompe disease.
- A normal carrier test in a parent does not exclude the possibility of their child having Pompe disease.
- Clinical suspicion is vital, even with seemingly normal prior genetic screening.
Implications:
- Healthcare providers must maintain a high clinical suspicion for Pompe disease, regardless of prenatal screening results.
- Limitations in the accuracy of parental recall of genetic testing can impact diagnosis.
- This case highlights the importance of considering Pompe disease in infants presenting with symptoms, even with a history of normal parental carrier screening.
Introduction:
Pompe disease is an autosomal recessive lysosomal storage disorder with marked morbidity and mortality, if untreated. With the advent of enzyme replacement therapy, it is essential to identify the infantile-type as early as possible to mitigate the effects of the enzyme deficiency. Identification is possible prenatally with testing of both parents. More recently, many states have instituted newborn screening for this condition.
Case:
We report a patient with infantile-onset Pompe disease with a normal paternal carrier genetic test, born prior to newborn screening for Pompe disease in the state of Michigan. The infant's father was retested once the infant was diagnosed with Pompe disease postnatally and noted to have a mutation conducive to Pompe disease.
Conclusion:
Providers should have a strong clinical suspicion for disorders even if prenatal parental carrier screening is normal. A normal parental prenatal test does not exclude the possibility that the fetus may be diagnosed with a disorder postnatally, and pediatricians may be faced with limitations in accuracy of parents' recollection of parental testing results.
Related Concept Videos
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Mitral Valve Prolapse III: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction

